ClinicalTrials.Veeva

Menu

RAFF5 Proposal: Improve the Quality and Safety of Patients Seen in the Emergency Department for Acute Atrial Fibrillation and Flutter

O

Ottawa Hospital Research Institute

Status

Completed

Conditions

Atrial Flutter
Atrial Fibrillation

Treatments

Other: Checklist implementation

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Acute atrial fibrillation (AF) and flutter (AFL) are the most common arrhythmias requiring management in the emergency department (ED). They are characterized by sudden onset of a rapid heart rate which may be irregular (AF) or regular (AFL). Our focus is on episodes of acute AF or AFL which are usually less than 48 hours in duration and are highly symptomatic, requiring rapid treatment in the ED. Management guidelines for acute AF/AFL have changed substantially in recent years with several recent revisions published by the Canadian Cardiovascular Society (CCS) and the Canadian Association of Emergency Physicians (CAEP). The 2021 CAEP Acute Atrial Fibrillation/Flutter Best Practices Checklist (CAEP Checklist) was very recently published to assist ED physicians in Canada and elsewhere manage patients who present to the ED with acute AF/AFL (Figure 1).

The overall goal of this project is to improve the quality and safety of the immediate and subsequent care of patients seen in the ED with acute AF and AFL by implementing the principles of the CAEP Checklist at both The Ottawa Hospital (TOH) EDs and by working with TOH cardiologists to provide rapid cardiology follow-up processes for patients discharged from the ED. The Investigators propose a before-after cohort study using an interrupted time series design to evaluate implementation involving 720 patients at the two TOH EDs over a 24-month period.

Enrollment

1,108 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • include all eligible patient visits to the participating EDs during the study period regardless of how they are managed.
  • include stable patients aged 18 and over,
  • presenting with an episode of acute AF or AFL of at least 3 hours duration,
  • where symptoms require ED management by rhythm or rate control.

Exclusion criteria

  • The study will exclude patients who have any of:

    1. permanent AF;
    2. deemed unstable and required immediate electrical cardioversion; or
    3. primary presentation was for another condition rather than arrhythmia.

Trial design

1,108 participants in 2 patient groups

Before Period
Description:
The before period (12 months) serves as the control period prior to implementation; data will be collected by health records review.
After Period
Description:
The after period (12 months) will be when patients are prospectively enrolled, and outcomes assessed.
Treatment:
Other: Checklist implementation

Trial contacts and locations

1

Loading...

Central trial contact

Ian Stiell, MD; Sara Khaksari

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems